Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T17:37:31.562Z.
Consensus retrieved: 2026-10-06T14:34:08.435Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T17:37:31.562Z.
Quote observation: 2026-10-06T17:35:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ffce46548baf09eb68ba264c0fe19ed309a9d25018129ed05cb07bb19ae3cea1
Forward PE Ratio (N/A) = Dated Quote Price ($15.33) / Consensus Forward EPS ($-1.24)
FORWARD PE RATIO
N/A
Novocure Ltd
Market Cap
$1.79B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Novocure Ltd (NVCR) | $1.79B | N/A |
| Absci Corporation (ABSI)vs › | $1.78B | N/A |
| Novavax, Inc. (NVAX)vs › | $1.80B | N/A |
| Generate Biomedicines, Inc. (GENB)vs › | $1.80B | N/A |
| Xencor, Inc. (XNCR)vs › | $1.81B | N/A |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 46.68 |
| Surgery Partners, Inc. (SGRY)vs › | $1.76B | 32.97 |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.82B | 5.35 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 27.70 |
| Azenta, Inc. (AZTA)vs › | $1.83B | 79.77 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $15.33, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-1.24 | $-1.40 – $-1.07 | 6 | n/m |
| 2027-12-31 | $-0.81 | $-1.22 – $-0.25 | 6 | n/m |
| 2028-12-31 | $-0.37 | $-0.68 – $-0.22 | 4 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
